Chiesi Breakfast Symposium - Inhale, Exhale, Innovate: Breathing Sustainability into Inhaler Design
Sunday, March 23, 2025 |
7:15 AM - 8:15 AM |
E2 |
Sponsored By:
Chiesi Australia
|
Details
Understanding the aspects of respiratory medicine that contribute to climate change is a critical first step in mitigating emissions. Some actions can be taken by individuals whilst others must be taken by the pharmaceutical industry who have an obligation to invest in technology to lower the global warming potential of the propellants in currently available pMDIs (considered F-gases).
This session presents technologies and strategies to reduce carbon emissions in respiratory medicine while maintaining patient care and patient choice.
Prof John Blakey will cover the development of carbon-minimal inhalers, outlining the pathway from preclinical research to commercialisation and provide a review of current programs.
Prof. Christine Jenkins will address the environmental impact of SABA overuse, a major source of emissions in asthma treatment, and discuss clinical strategies to manage overuse, improve asthma control, and reduce environmental harm.
Finally, new research on Maintenance and Reliever Therapy (MART) will be presented by Prof David Price highlighting the potential for MART to reduce greenhouse gas emissions while maintaining asthma control.
The session aims to equip healthcare professionals with the tools to transition to high value, low carbon healthcare.
Speaker
Prof Christine Jenkins
Head, Respiratory Group
The George Institute for Global Health
Inhale, Exhale, Innovate: Breathing Sustainability into Inhaler Design
7:15 AM - 8:15 AMBiography
Christine Jenkins is Head of the Respiratory Group at The George Institute for Global Health; Senior Staff Specialist in Thoracic Medicine at Concord Hospital, Sydney; Clinical Professor and Head of Respiratory Discipline at University of Sydney; and Professor of Respiratory Medicine at UNSW Sydney.
Prof. Jenkins has been Principal Investigator and has led many investigator-initiated and competitively funded clinical trials in airways disease. She is an active clinician and has had major roles in advocacy and leadership for lung health in Australia, chairing many local and international guidelines and implementation initiatives to enhance resources, skills, capacity and clinical outcomes in airways disease. She is on the Board of the Lung Foundation Australia, and is a member of the Thoracic Society of Australia and New Zealand, the American Thoracic Society, European Respiratory Society and the Asia-Pacific Society of Respirology.
Prof David Price
Director Of Observational and Pragmatic Research Institute
Observational and Pragmatic Research Institute
Inhale, Exhale, Innovate: Breathing Sustainability into Inhaler Design
7:15 AM - 8:15 AMBiography
Founder, Optimum Patient Care; Founder, The Observational and Pragmatic Research Institute; Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine, University of Aberdeen.
Prof David Price is founder and head of Optimum Patient Care (UK and Australia), a science-based, social enterprise which focuses on disease registries and supporting care in primary and secondary care led by internationally recognised experts in all areas of respiratory medicine. He is also the founder of The Observational and Pragmatic Research Institute (Singapore), an independent, research-driven organisation established to cultivate initiatives, provide evidence and drive quality standards within the growing field of real-life, pragmatic and observational research.
Prof Helen Reddel
Research Leader
Woolcock Institute of Medical Research / Macquarie University
Inhale, Exhale, Innovate: Breathing Sustainability into Inhaler Design
7:15 AM - 8:15 AMBiography
Professor Reddel is a Research Leader and NHMRC Leadership Fellow at the Woolcock Institute of Medical Research, Macquarie University. She is Chair of the Global Initiative for Asthma (GINA) Science Committee.
Prof John Blakey
Respiratory and Sleep Medicine Consultant
Sir Charles Gardner Hospital
Inhale, exhale, innovate: Breathing sustainability into inhaler design
7:15 AM - 8:15 AMBiography
Internationally renowned respiratory expert, John Blakey is a Respiratory Physician at Sir Charles Gairdner Hospital with a clinical interest in asthma. He is an advisor for Asthma Australia and Respiratory Care WA, and is the Immediate Past President of TSANZ WA. His main research interest is in health service delivery for airways disease. His research has been published in leading journals such as The Lancet, JACI, Thorax, and AJRCCM.
